ArticleOrganic letters2016
Accessing Elaborated 2,1-Borazaronaphthalene Cores Using Photoredox/Nickel Dual-Catalytic Functionalization.
Article in Organic letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Selectivity in the Elaboration of Bicyclic Borazarenes.Advanced synthesis & catalysis · 2021Article
- Generation of Alkyl Radicals: From the Tyranny of Tin to the Photon Democracy.Chemical reviews · 2020Article
- Recent advances in photoredox and nickel dual-catalyzed cascade reactions: pushing the boundaries of complexity.Chemical science · 2020Review
- Late-stage functionalization of BN-heterocycles.Chemical Society reviews · 2019Article
- Photoredox Catalysis Enables Access to N-Functionalized 2,1-Borazaronaphthalenes.Organic letters · 2019Article
- The State of the Art in Azaborine Chemistry: New Synthetic Methods and Applications.Journal of the American Chemical Society · 2018Review
- Regioselective Diversification of 2,1-Borazaronaphthalenes: Unlocking Isosteric Space via C-H Activation.The Journal of organic chemistry · 2017Article
- Azaborininones: Synthesis and Structural Analysis of a Carbonyl-Containing Class of Azaborines.The Journal of organic chemistry · 2017Article
- Medicinal Chemistry Profiling of Monocyclic 1,2-Azaborines.ChemMedChem · 2017Article
- Mild, Redox-Neutral Alkylation of Imines Enabled by an Organic Photocatalyst.ACS catalysis · 2017Article
- Preparation of visible-light-activated metal complexes and their use in photoredox/nickel dual catalysis.Nature protocols · 2017Article
- Method for Accessing Nitrogen-Containing, B-Heteroaryl-Substituted 2,1-Borazaronaphthalenes.The Journal of organic chemistry · 2017Article
- Preparation of Diisopropylammonium Bis(catecholato)cyclohexylsilicate.Organic syntheses; an annual publication of satisfactory methods for the preparation of organic chemicals · 2017Article
- C(spChemical science · 2017Article
- Photoredox Catalysis in Organic Chemistry.The Journal of organic chemistry · 2016Article
- Single-Electron Transmetalation via Photoredox/Nickel Dual Catalysis: Unlocking a New Paradigm for sp(3)-sp(2) Cross-Coupling.Accounts of chemical research · 2016Article
- Photoredox Catalysis Unlocks Single-Electron Elementary Steps in Transition Metal Catalyzed Cross-Coupling.ACS central science · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A highly effective method for derivatizing 2,1-borazaronaphthalene cores using ammonium alkylbis(catecholato)silicates via photoredox/nickel dual catalysis is reported. By forging C(sp)(3)-C(sp)(2) bonds via this approach, alkyl fragments with various functional groups can be introduced to the azaborine core, affording previously inaccessible heterocyclic isosteres in good to excellent yields. The base-free, room-temperature conditions outlined allow sensitive functional group tolerance, even permitting the cross-coupling of unprotected primary and secondary amines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.